APTEVO THERAPEUTICS INC.— Sankey Diagram

Quarterly mode · period ending 2022-12-31 · SEC EDGAR

ComparingFY2022 (Q1+Q2+Q3+Q4) vs FY2021 (Q1+Q2+Q3+Q4)
Revenue
$3M
↓-74.7% -$9Mvs FY2021 (Q1+Q2+Q3+Q4)
Gross Profit
$3M
↓-74.7% -$9Mvs FY2021 (Q1+Q2+Q3+Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
Reconciled values per the quarterly mode pipeline. Compare against SEC EDGAR filings.
Line itemFY2022 (Q1+Q2+Q3+Q4)FY2021 (Q1+Q2+Q3+Q4)
Revenue$3M$12M
COGS$0$0
Gross Profit$3M$12M
R&D$18M$19M
SG&A$0$0
D&A$901K$1M
Other OpEx$0$0
Operating Income$0$0
Interest Exp.$0$0
Other Non-Op$0$0
Pretax Income$0$0
Tax$0$0
Net Income$0$0

QuarterCharts · SEC EDGAR data · APVO · Comparing FY2022 (Q1+Q2+Q3+Q4) vs FY2021 (Q1+Q2+Q3+Q4)